Jack And Jill Late Stage Cancerfoundation Inc

Jack And Jill Late Stage Cancerfoundation Inc consistently grows assets with zero reported officer compensation.

EIN: 204415512 · Atlanta, GA · NTEE: G19 · Updated: 2026-03-28

$1.6MRevenue

$1.9MAssets

92/100Mission Score (Excellent)

G19

About Jack And Jill Late Stage Cancerfoundation Inc

Jack And Jill Late Stage Cancerfoundation Inc (EIN: 204415512) is a nonprofit organization based in Atlanta, GA, classified under NTEE code G19. The organization reported total revenue of $1.6M and total assets of $1.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Jack And Jill Late Stage Cancerfoundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Jack And Jill Late Stage Cancerfoundation Inc demonstrates consistent financial activity, with revenues generally exceeding expenses in recent years, contributing to a steady growth in assets. For instance, in 2022, revenue was $1,449,888 against expenses of $1,153,661, leading to an increase in assets to $1,791,868. The organization's liabilities have consistently been very low or zero across all reported periods, indicating strong financial management and minimal debt burden. This suggests a healthy balance sheet and responsible handling of funds.

The organization's transparency is notably high regarding executive compensation, as all filings indicate 0% officer compensation. This practice is commendable and suggests that resources are primarily directed towards program services and operational needs rather than high executive salaries. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall financial health and lack of officer compensation are positive indicators of fiscal responsibility. The consistent growth in assets over the past decade, from $238,220 in 2015 to $1,787,578 in 2023, further underscores its financial stability and ability to build reserves.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Jack And Jill Late Stage Cancerfoundation Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 10%
programs: 85%
fundraising: 5%

According to IRS 990 filings, Jack And Jill Late Stage Cancerfoundation Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

Executive compensation is reported as 0% across all available filings, which is exceptional for an organization of its size with revenues consistently over $1 million, indicating a strong commitment to directing funds to its mission.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Strengths

The following positive indicators were identified for Jack And Jill Late Stage Cancerfoundation Inc:

Consistent asset growth, from $238,220 in 2015 to $1,787,578 in 2023.
Zero reported officer compensation across all filings, indicating high efficiency.
Very low or zero liabilities, demonstrating strong financial management.
Revenues generally exceed expenses, contributing to financial stability.
Long history of consistent IRS 990 filings (13 filings), indicating transparency.

Frequently Asked Questions about Jack And Jill Late Stage Cancerfoundation Inc

Is Jack And Jill Late Stage Cancerfoundation Inc a good charity?

Based on the provided data, the organization appears to be a good charity. It demonstrates strong financial health with growing assets and very low liabilities, and notably, reports 0% officer compensation, indicating a high dedication to its mission.

How has the organization's financial health changed over time?

The organization has shown consistent financial growth. Assets have increased significantly from $238,220 in 2015 to $1,787,578 in 2023, and revenues have generally exceeded expenses, contributing to this positive trend.

What is the organization's approach to executive compensation?

The organization reports 0% officer compensation in all available filings, which is a highly positive indicator of its commitment to minimizing overhead and maximizing resources for its programs.

Are there any concerns regarding the organization's liabilities?

No, the organization consistently reports very low or zero liabilities across all filing periods, indicating excellent financial management and minimal debt.

Filing History

IRS 990 filing history for Jack And Jill Late Stage Cancerfoundation Inc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Jack And Jill Late Stage Cancerfoundation Inc's revenue has grown by 6.4%, moving from $1.3M to $1.3M. Total assets increased by 1195.9% over the same period, from $138K to $1.8M. Total functional expenses rose by 5.5%, from $1.3M to $1.3M. In its most recent filing year (2023), Jack And Jill Late Stage Cancerfoundation Inc reported a deficit of $1K, with expenses exceeding revenue.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$1.3M	$1.3M	$1.8M	$0	—	View 990
2022	$1.4M	$1.2M	$1.8M	$3K	—	View 990
2021	$1.2M	$856K	$1.5M	$0	—	View 990
2020	$818K	$812K	$1.1M	$8K	—	View 990
2019	$1.4M	$1.2M	$1.1M	$11K	—	View 990
2018	$1.3M	$1.0M	$906K	$168	—	View 990
2017	$1.3M	$957K	$664K	$136	—	View 990
2016	$931K	$819K	$380K	$32K	—	View 990
2015	$979K	$1.1M	$238K	$3K	—	View 990
2014	$1.0M	$1.3M	$378K	$0	—	View 990
2013	$1.6M	$1.1M	$619K	$6K	—	View 990
2012	$1.2M	$1.2M	$142K	$72K	—	View 990
2011	$1.3M	$1.3M	$138K	$947	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $1.3M, expenses of $1.3M, and assets of $1.8M (revenue -8.0% year-over-year).
2022: Revenue of $1.4M, expenses of $1.2M, and assets of $1.8M (revenue +19.9% year-over-year).
2021: Revenue of $1.2M, expenses of $856K, and assets of $1.5M (revenue +47.8% year-over-year).
2020: Revenue of $818K, expenses of $812K, and assets of $1.1M (revenue -42.5% year-over-year).
2019: Revenue of $1.4M, expenses of $1.2M, and assets of $1.1M (revenue +13.1% year-over-year).
2018: Revenue of $1.3M, expenses of $1.0M, and assets of $906K (revenue -1.1% year-over-year).
2017: Revenue of $1.3M, expenses of $957K, and assets of $664K (revenue +36.7% year-over-year).
2016: Revenue of $931K, expenses of $819K, and assets of $380K (revenue -4.9% year-over-year).
2015: Revenue of $979K, expenses of $1.1M, and assets of $238K (revenue -6.1% year-over-year).
2014: Revenue of $1.0M, expenses of $1.3M, and assets of $378K (revenue -34.8% year-over-year).
2013: Revenue of $1.6M, expenses of $1.1M, and assets of $619K (revenue +35.7% year-over-year).
2012: Revenue of $1.2M, expenses of $1.2M, and assets of $142K (revenue -6.1% year-over-year).
2011: Revenue of $1.3M, expenses of $1.3M, and assets of $138K.

Data Sources and Methodology

This transparency report for Jack And Jill Late Stage Cancerfoundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.